The effect of probiotic strains on intestinal permeability in well-trained adults

ISRCTN ISRCTN16686476
DOI https://doi.org/10.1186/ISRCTN16686476
Secondary identifying numbers HND-GI-020
Submission date
06/11/2015
Registration date
06/11/2015
Last edited
21/01/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Probiotics are live bacteria and yeasts that are good for your health. They are often found in milk products such as yogurt and as food supplements. It is believed that regular consumption of probiotics has a beneficial effect on the digestive system. This study will investigate whether a capsule with a specific probiotic microorganism can improve intestinal permeability more than a capsule that does not contain probiotics (placebo).

Who can participate?
Healthy men and women aged 18 to 40 who train for 4 or more hours per week and experience
gastrointestinal symptoms that interfere with their training and during competition.

What does the study involve?
Participants are randomly allocated to take either one of two capsules containing two different probiotics or an identical capsule without probiotics (placebo) for 6 weeks. Participants provide urine and fecal samples, undergo exercise tests, and complete questionnaires on quality of life, food habits, physical activity and bowel habits.

What are the possible benefits and risks of participating?
The consumption of the probiotic capsule could lead to a general improvement in the partcipant’s well-being and has no known risks.

Where does the study take place?
Nutrition-Gut-Brain Interactions Research Centre (NGBI), Örebro University, Sweden

When is the study starting and how long is it expected to run for?
January 2015 to February 2016

Who is funding the study?
Chr. Hansen A/S (Denmark)

Who is the main contact?
Prof Robert Brummer

Contact information

Mr Adam Baker
Scientific

Boege Alle 10-12
Hoersholm
2970
Denmark

Study information

Study designRandomized double-blind placebo-controlled parallel-group study
Primary study designInterventional
Secondary study designRandomised parallel trial
Study setting(s)Not specified
Study typeNot Specified
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet.
Scientific titleInvestigational study on the effect of 6 weeks intake of two probiotic strains on exercise-induced intestinal permeability – a randomized, double-blind, placebo-controlled, three-armed parallel group study
Study acronymAPRO
Study objectivesThe study was designed to investigate the efficacy of daily consumption of two probiotic strains for 6 weeks on exercise-induced intestinal permeability and supporting biomarkers.
Ethics approval(s)Regionala etikprövningsnämnden (Regional Ethical Committee) i Uppsala, 18/03/2015 , ref: Dnr 2015/077
Health condition(s) or problem(s) studiedGastrointestinal function
InterventionParticipants are randomised to one of three treatment arms for six weeks:
1. A capsule containing a probiotic strain A
2. A capsule containing a probiotic strain B
3. A placebo capsule with no probiotics
Intervention typeSupplement
Primary outcome measureIntestinal permeability after a standardized exercise challenge measured by the in vivo lactulose/rhamnose sugar test at baseline and end of intervention (after 6 weeks)
Secondary outcome measuresMultiple potential biomarkers measured in blood, feces and saliva at baseline and end of intervention (after 6 weeks)
Overall study start date01/01/2015
Completion date01/02/2016

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants48
Key inclusion criteria1. Healthy men or women
2. Age 18 to 40 inclusive
3. Presence of upper or lower gastrointestinal symptoms that interfere with training and during competition
4. Weekly training load of 4 or more hours within endurance sports (minimum 50% of the training should be running activity)
Key exclusion criteria1. History of hypersensitivity to any of the ingredients of the study products or lactose intolerance
2. History or diagnosis of gastrointestinal disease or complicated gastrointestinal surgery
3. Any physical or psychological abnormality or medical condition that could have an effect on gastrointestinal discomfort
4. Participation in any other clinical study
5. Not willing or able to provide written informed consent for participation in the study
6. For women: Not willing and able to use a reliable contraceptive method, pregnancy, lactation or wish to become pregnant
Date of first enrolment21/09/2015
Date of final enrolment31/12/2015

Locations

Countries of recruitment

  • Sweden

Study participating centre

Örebro University
Nutrition-Gut-Brain Interactions Research Centre (NGBI)
701 82
Sweden

Sponsor information

Chr. Hansen A/S (Denmark)
Industry

Boege Alle 10-12
Hoersholm
2970
Denmark

ROR logo "ROR" https://ror.org/01mv6bt66

Funders

Funder type

Industry

Chr. Hansen A/S (Denmark)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planTo be confirmed at a later date
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 23/05/2024 21/01/2025 Yes No

Editorial Notes

21/01/2025: Publication reference added.